Isodiol International Inc. Signs Definitive Licensing Agreement With Canopy Growth Corporation for Canadian and International...
July 20 2017 - 7:15AM
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF)
(Frankfurt:LB6A.F)
(the “Company” or
“Isodiol”) a global cannabis innovator specializing in the
development of pharmaceutical and consumer products is pleased to
announce it has signed a licensing agreement with Canopy Growth
Corporation (“Canopy”) (TSX:WEED)
(https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis
company that operates a collection of diverse brands and curated
strain varieties, supported by over half a million square feet of
indoor and greenhouse production capacity. Under this licensing
agreement, Canopy Growth will have the right to manufacture and
distribute the Company's "Pot-O-Coffee" and "Pot-O-Tea" branded
marijuana infused single serve K-Cup products in Canada and certain
other markets internationally as federal regulations allow.
Licensed products include caffeinated and de-caffeinated product
lines as well as Isodiol's single serve "Pot-O-Coco". In addition
to the Canadian rights, Canopy Growth shall have the right of first
refusal to sell the "Pot-O" brand products in any territory outside
of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned
to increase our global footprint with the largest cannabis company
in the world. We will continue to develop our Pot-O-Coffee product
lines with ready to drink and cold brew products while working with
Canopy Growth for international distribution channels. The
Pot-O-Coffee brand is well recognized, and adding additional
products to this line will continue to strengthen its market
presence," stated Isodiol's CEO Marcos Agramont.
The availability of the various licensed
products in Canada and elsewhere will differ depending on
applicable laws and regulation. While Canadian law does not yet
permit the manufacture and sale of marijuana infused products, the
Company anticipates that such products will be permitted in the
near future. Furthermore, currently proposed regulations which
would permit the sale of infused products, would not allow such
products to contain both marijuana and caffeine. As such, the
specific product offerings in Canada and elsewhere may be limited.
The Company will provide additional updates as regulations are
adopted and as product roll-out plans are developed.
About Isodiol International
Inc.
Isodiol International, Inc. is the market leader in
pharmaceutical grade cannabis compounds and the industry leader in
manufacturing and development of consumer products. Isodiol's
nutraceutical division is the pioneer of many firsts for
Hemp-derived cannabidiol (CBD), including 99% pure crystalline
isolate, micro-encapsulation, and nano technology for the highest
quality consumable and topical skin care products.
Isodiol's growth strategy includes the
development of over-the-counter and pharmaceutical
drugs, seeking joint ventures and acquisitions to expand its
portfolio of brands and subsidiaries and will aggressively continue
International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD |
CORPORATE MEDIA: |
“Marcos
Agramont” |
ir@isodiol.com |
CEO & Director |
www.isodiol.com |
|
Join Us On Facebook:
https://www.facebook.com/isodiol/ Twitter: @isodiol |
Forward-Looking Information:
This news release contains "forward-looking information" within the
meaning of applicable securities laws relating to statements
regarding the Company's business, products and future the Company’s
business, its product offerings and plans for sales and marketing.
Although the Company believes that the expectations reflected in
the forward looking information are reasonable, there can be no
assurance that such expectations will prove to be correct. Readers
are cautioned to not place undue reliance on forward-looking
information. Such forward looking statements are subject to risks
and uncertainties that may cause actual results, performance and
developments to differ materially from those contemplated by these
statements depending on, among other things, the risks that the
Company's products and plan will vary from those stated in this
news release and the Company may not be able to carry out its
business plans as expected. Except as required by law, the Company
expressly disclaims any obligation, and does not intend, to update
any forward looking statements or forward-looking information in
this news release. Although the Company believes that the
expectations reflected in the forward looking information are
reasonable, there can be no assurance that such expectations will
prove to be correct and makes no reference to profitability based
on sales reported. The statements in this news release are made as
of the date of this release.
The CSE has not reviewed, approved or disapproved
the content of this press release.
Canopy Growth (TSX:WEED)
Historical Stock Chart
From Apr 2024 to May 2024
Canopy Growth (TSX:WEED)
Historical Stock Chart
From May 2023 to May 2024